Personalis Total Liabilities and Share Holders Equity 2018-2024 | PSNL
Personalis total liabilities and share holders equity from 2018 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
Personalis Annual Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2023 |
$225 |
| 2022 |
$293 |
| 2021 |
$397 |
| 2020 |
$245 |
| 2019 |
$157 |
| 2018 |
$42 |
| 2017 |
$0 |
Personalis Quarterly Total Liabilities and Share Holders Equity
(Millions of US $) |
| 2024-06-30 |
$186 |
| 2024-03-31 |
$195 |
| 2023-12-31 |
$225 |
| 2023-09-30 |
$227 |
| 2023-06-30 |
$249 |
| 2023-03-31 |
$272 |
| 2022-12-31 |
$293 |
| 2022-09-30 |
$318 |
| 2022-06-30 |
$358 |
| 2022-03-31 |
$381 |
| 2021-12-31 |
$397 |
| 2021-09-30 |
$407 |
| 2021-06-30 |
$383 |
| 2021-03-31 |
$396 |
| 2020-12-31 |
$245 |
| 2020-09-30 |
$249 |
| 2020-06-30 |
$146 |
| 2020-03-31 |
$152 |
| 2019-12-31 |
$157 |
| 2019-09-30 |
$160 |
| 2019-06-30 |
$192 |
| 2019-03-31 |
$0 |
| 2018-12-31 |
|
| 2018-09-30 |
$0 |
| 2018-06-30 |
$0 |
| 2017-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.315B |
$0.073B |
|
Personalis Inc. is a cancer genomics company. It is engaged in the development of therapies by providing molecular data about each patient's cancer and immune response. Personalis Inc. is based in Menlo Park, California.
|
